Table 1. Serum chemistry profiles of the patients included in this study.
Category | Gender (M/F) | Age | T. bilirubin | Aspartate aminotransferase | Alanine aminotransferase | Creatinine |
Reference range | 0.9–1.8 (mg/dL) | 13.0–34.0 (IU/L) | 5.0–46.0 (IU/L) | 0.68–1.19 (mg/dL) | ||
Hepatocellular carcinoma (n = 75) | 56/19 | 56.5±10.5 | 0.72±0.31 | 37.8±22.7 | 38.3±29.3 | 0.86±0.20 |
Colorectal cancer (n = 15) | 5/10 | 58.1±12.0 | 0.52±0.20 | 24.3±21.8 | 17.7±14.9 | 0.83±0.25 |
Cholangiocarcinoma (n = 5) | 3/2 | 62.0±10.6 | 0.74±0.34 | 33.6±13.0 | 42.2±18.9 | 0.84±0.18 |
Stomach cancer* (n = 3) | 3/0 | 61–75 | 0.6–1.0 | 28–52 | 30–60 | 0.85–0.91 |
Others (n = 7) | 2/5 | 38.3±17.9 | 0.63±0.23 | 19.9±7.5 | 18.1±6.3 | 0.70±0.18 |
Values are mean±standard deviation, except for a group(*) that included too few patients to perform statistical analysis. In this group, values were displayed as the range instead.